8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): November 27, 2007

Merck & Co., Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

New Jersey	1-3305	22-1109110
_____________________ (State or other jurisdiction	_____________ (Commission	______________ (I.R.S. Employer
of incorporation)	File Number)	Identification No.)
One Merck Drive, P.O. Box 100, Whitehouse Station, New Jersey		08889
_________________________________ (Address of principal executive offices)		___________ (Zip Code)

Registrant’s telephone number, including area code: 908-423-1000

Not Applicable
______________________________________________
Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d) Incorporated by reference is a press release issued by Merck & Co., Inc. (the "Company") on November 26, 2007, attached as Exhibit 99.1, announcing the election of Thomas H. Glocer to the Company's Board of Directors, effective November 27, 2007. Board Committee assignments for Mr. Glocer will be determined at a later date.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit 99.1 Press Release issued November 26, 2007

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Merck & Co., Inc.
November 27, 2007	By:	/s/ Debra A. Bollwage
		Name: Debra A. Bollwage
		Title: Senior Assistant Secretary

Exhibit Index

Exhibit No.	Description
99.1	Press release issued November 26, 2007

EX-99.1

Exhibit 99.1

MERCK LOGO

News Release

Media Contact: Christopher Garland
(908) 423-3461 Investor Contact: Graeme Bell
(908) 423-5185

Thomas H. Glocer Elected to Merck Board of Directors

WHITEHOUSE STATION, N.J., Nov. 26, 2007 – Merck & Co., Inc. today announced that Thomas H. Glocer, 48, Chief Executive Officer, Reuters Group PLC, will join the Company’s Board of Directors effective Nov. 27. With his election, Mr. Glocer will become one of 11 outside directors on the 12-member board. Mr. Glocer will stand for election by the Company’s stockholders in April 2008.

Mr. Glocer joined Reuters Group in New York in 1993 and was appointed Chief Executive Officer of Reuters America in 1999. In February 2000, he was appointed Chief Executive Officer, Reuters Information, and was appointed to the Reuters Board in June of that same year. Mr. Glocer was named Chief Executive Officer of Reuters Group PLC in July 2001.

Prior to joining Reuters, Mr. Glocer was a mergers and acquisitions lawyer with Davis Polk & Wardwell in New York, Paris and Tokyo.

Mr. Glocer is a member of the International Advisory Board of British American Business Inc., the Advisory Board of the Judge Institute of Management at Cambridge University, the European Business Leaders Council, the Corporate Advisory Group of Tate Britain and The Madison Council of the Library of Congress. He is also active in several public education initiatives in New York City and London.

A graduate of Columbia University, Mr. Glocer earned a bachelor’s degree in political science. He earned his law degree from Yale Law School.

About Merck

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit www.merck.com.

# # #